Expansion Therapeutics, Inc.

Industry

  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Technologies
    • Antisense, Oligonucleotides

Other Names/Subsidiaries

  • 5AM Ventures
See more in Biomedtracker

Latest on Expansion Therapeutics, Inc.

Scrip

Tech Transfer Roundup: Sanofi Gets IP For Multiple Myeloma From Memorial Sloan Kettering

 
• By Joseph Haas

Sanofi Gets IP From MSKCC, Eureka Applicable In Multiple Myeloma Therapy Sanofi signed an agreement on 6 July to acquire intellectual property covering non-chimeric antigen receptor (CAR) use of a n

Scrip

Arrakis Pivots From Platform To Pipeline With $75m For RNA-Targeting Small Molecules

 
• By Mandy Jackson

Arrakis Therapeutics Inc. is in the middle of a big pivot from building its platform for the discovery of small molecules that target RNA to generating a pipeline of drug candidates – and now it has

Scrip

Deal Watch: Purdue Continues Move Away From Opioids With Alivio Deal

 
• By Joseph Haas, Jo Shorthouse, Ian Haydock, and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Purdue Partners With Alivio

Scrip

Venture Funding Deals: BioNTech's Big Money Leads January Financings

 
• By Deanna Kamienski

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar